HuGE Literature Finder
Records
1
-
23
| Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Sep . Momeni Boroujeni Amir, Kertowidjojo Elizabeth, Wu Xinyu, Soslow Robert A, Chiang Sarah, Da Silva Edaise M, Weigelt Britta, Chui M Herm |
| Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC cancer 2021 2 21 (1): 199. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Chao Ta-Chung, Lien Pei-Ju, Lin Yen-Shu, Feng Chin-Jung, Chiu Jen-Hwey, Hsu Chih-Yi, Tseng Ling-Mi |
| Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis. Cancer treatment and research communications 2021 5 27 100374. Diez-Calzadilla N A, Noguera Salvá R, Soriano Sarrió P, Martínez-Jabaloyas J |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (3): 967-976. Audenet François, Isharwal Sumit, Cha Eugene K, Donoghue Mark T A, Drill Esther N, Ostrovnaya Irina, Pietzak Eugene J, Sfakianos John P, Bagrodia Aditya, Murugan Paari, Dalbagni Guido, Donahue Timothy F, Rosenberg Jonathan E, Bajorin Dean F, Arcila Maria E, Hechtman Jaclyn F, Berger Michael F, Taylor Barry S, Al-Ahmadie Hikmat, Iyer Gopa, Bochner Bernard H, Coleman Jonathan A, Solit David |
| High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior. The American journal of surgical pathology 2017 Aug . Hodgson Anjelica, Amemiya Yutaka, Seth Arun, Djordjevic Bojana, Parra-Herran Carl |
| Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Scientific reports 2017 Jan 7 39765. Zhang Yang, Sturgis Erich M, Li Yuncheng, Wei Qingyi, Huang Zhigang, Li Guoj |
| Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma. The Journal of urology 2016 Jan . Bagrodia Aditya, Cha Eugene K, Sfakianos John P, Zabor Emily C, Bochner Bernard H, Al-Ahmadie Hikmat A, Solit David B, Coleman Jonathan |
| Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study. Acta oto-laryngologica 2015 Sep 1-5. Zhou Jian, Yang Yue, Zhang Duo, Zhou Liang, Liu Fei, Tao Lei, Lu Li-Mi |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis. OncoTargets and therapy 2015 8 3679-90. Xie Linguo, Sun Yan, Chen Tao, Tian Dawei, Li Yujuan, Zhang Yu, Ding Na, Shen Zhonghua, Xu Hao, Nian Xuewu, Sha Nan, Han Ruifa, Hu Hailong, Wu Chang |
| Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences 2014 15 (7): 12458-68. Salvi Samanta, Calistri Daniele, Gurioli Giorgia, Carretta Elisa, Serra Luigi, Gunelli Roberta, Zoli Wainer, Casadio Valenti |
| Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein & cell 2013 Jan 4 (1): 1. Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W |
| MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1. BMC urology 2013 13 (1): 5. Olsson Hans, Hultman Per, Rosell Johan, Söderkvist Peter, Jahnson Staff |
| Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma. The Journal of investigative dermatology 2012 May 132 (5): 1471-8. Cotignola Javier, Chou Joanne F, Roy Pampa, Mitra Nandita, Busam Klaus, Halpern Allan C, Orlow Ire |
| Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study. Journal of gastroenterology and hepatology 2012 Apr 27 (4): 797-804. Tomoda Takeshi, Nouso Kazuhiro, Sakai Akiko, Ouchida Mamoru, Kobayashi Sayo, Miyahara Koji, Onishi Hideki, Nakamura Shinichiro, Yamamoto Kazuhide, Shimizu Ken |
| Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA and cell biology 2010 Jul 29 (7): 349-56. Gangwar Ruchika, Mittal Rama De |
| p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a southern Chinese population. Urologia internationalis 2010 85 (4): 401-5. Xu Bin, Mi Yuan-Yuan, Min Zhi-Chao, Cheng Gong, Tong Na, Tao Jun, Li Peng-Chao, Wang Mei-Lin, Tang Jia-Lin, Zhang Zheng-Dong, Song Ning-Hong, Zhang Wei, Wu Hong-Fei, Feng Ning-Han, Hua Li-X |
| Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. The Journal of urology 2009 Apr 181 (4): 1907-12. Hirata Hiroshi, Hinoda Yuji, Kikuno Nobuyuki, Suehiro Yutaka, Shahryari Varahram, Ahmad Ardalan E, Tabatabai Z Laura, Igawa Mikio, Dahiya Rajv |
| Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncology reports 2008 Jul 20 (1): 49-55. Horikawa Yohei, Nadaoka Junichi, Saito Mitsuru, Kumazawa Teruaki, Inoue Takamitu, Yuasa Takeshi, Tsuchiya Norihiko, Nishiyama Hiroyuki, Ogawa Osamu, Habuchi Tomono |
| MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008 May 87 (2): 243-52. Tu Hsi-Feng, Chen Hong-Wen, Kao Shou-Yen, Lin Shu-Chun, Liu Chung-Ji, Chang Kuo-W |
| Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast cancer research : BCR 2007 9 (3): R34. Toyama Tatsuya, Zhang Zhenhuan, Nishio Mariko, Hamaguchi Maho, Kondo Naoto, Iwase Hirotaka, Iwata Hiroji, Takahashi Satoru, Yamashita Hiroko, Fujii Yoshita |
| No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes. Urologic oncology 0 29 (3): 319-23. Jaboin Jerry J, Hwang Misun, Perez Carmen A, Cooper Calvin, Chen Heidi, Ye Chuanzhong, Cai Qiuyin, Wills Marcia L, Lu |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: